BRIC Hematology Market Outlook to 2024

Published : Dec-2017

No. of Pages : 262

order by fax Inquire before Buying request discount

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 10
2.1 What Is This Report About? 10
2.2 Hematology Market Segmentation 10
2.3 Definitions of Markets Covered in the Report 11
3 Hematology Market, BRIC 15
3.1 Hematology Market, BRIC, Revenue ($m), 2010-2024 15
3.2 Hematology Market, BRIC, Category Comparison by Revenue ($m), 2010-2024 17
3.3 Hematology Market, BRIC, Revenue ($m), 2010-2017 19
3.4 Hematology Market, BRIC, Revenue ($m), 2017-2024 21
3.5 Hematology Market, BRIC, Volume (Units), 2010-2024 23
3.6 Hematology Market, BRIC, Volume (Units), 2010-2017 25
3.7 Hematology Market, BRIC, Volume (Units), 2017-2024 27
3.8 Hematology Market, BRIC, Company Share by Revenue ($m), 2017 29
4 Hematology Market, Brazil 31
4.1 Hematology Market, Brazil, Revenue ($m), 2010-2017 31
4.2 Hematology Market, Brazil, Revenue ($m), 2017-2024 33
4.2.1 Hematology Analyzers Market, Brazil, Revenue ($m), by Segment, 2010-2017 35
4.2.2 Hematology Cell Counters Market, Brazil, Revenue ($m), by Segment, 2010-2017 37
4.2.3 Hematology Rapid Tests & POC Market, Brazil, Revenue ($m), by Segment, 2010-2017 39
4.2.4 Hematology Reagents Market, Brazil, Revenue ($m), by Segment, 2010-2017 41
4.2.5 Hemostasis Market, Brazil, Revenue ($m), by Segment, 2010-2017 43
4.2.6 Immunohematology Market, Brazil, Revenue ($m), by Segment, 2010-2017 45
4.2.7 Hematology Analyzers Market, Brazil, Revenue ($m), by Segment, 2017-2024 47
4.2.8 Hematology Cell Counters Market, Brazil, Revenue ($m), by Segment, 2017-2024 49
4.2.9 Hematology Rapid Tests & POC Market, Brazil, Revenue ($m), by Segment, 2017-2024 51
4.2.10 Hematology Reagents Market, Brazil, Revenue ($m), by Segment, 2017-2024 53
4.2.11 Hemostasis Market, Brazil, Revenue ($m), by Segment, 2017-2024 55
4.2.12 Immunohematology Market, Brazil, Revenue ($m), by Segment, 2017-2024 57
4.3 Hematology Market, Brazil, Volume (Units), 2010-2017 59
4.4 Hematology Market, Brazil, Volume (Units), 2017-2024 61
4.4.1 Hematology Analyzers Market, Brazil, Volume (Units), by Segment, 2010-2017 63
4.4.2 Hematology Rapid Tests & POC Market, Brazil, Volume (Units), by Segment, 2010-2017 65
4.4.3 Hematology Reagents Market, Brazil, Volume (Units), by Segment, 2010-2017 67
4.4.4 Hemostasis Market, Brazil, Volume (Units), by Segment, 2010-2017 69
4.4.5 Hematology Analyzers Market, Brazil, Volume (Units), by Segment, 2017-2024 71
4.4.6 Hematology Rapid Tests & POC Market, Brazil, Volume (Units), by Segment, 2017-2024 73
4.4.7 Hematology Reagents Market, Brazil, Volume (Units), by Segment, 2017-2024 75
4.4.8 Hemostasis Market, Brazil, Volume (Units), by Segment, 2017-2024 77
4.5 Hematology Market, Brazil, Average Price ($), 2010-2024 79
4.6 Hematology Market, Brazil, Distribution Share by Revenue ($m), 2017 83
4.7 Hematology Market, Brazil, Company Share by Revenue ($m), 2017 84
5 Hematology Market, China 86
5.1 Hematology Market, China, Revenue ($m), 2010-2017 86
5.2 Hematology Market, China, Revenue ($m), 2017-2024 88
5.2.1 Hematology Analyzers Market, China, Revenue ($m), by Segment, 2010-2017 90
5.2.2 Hematology Cell Counters Market, China, Revenue ($m), by Segment, 2010-2017 92
5.2.3 Hematology Rapid Tests & POC Market, China, Revenue ($m), by Segment, 2010-2017 94
5.2.4 Hematology Reagents Market, China, Revenue ($m), by Segment, 2010-2017 96
5.2.5 Hemostasis Market, China, Revenue ($m), by Segment, 2010-2017 98
5.2.6 Immunohematology Market, China, Revenue ($m), by Segment, 2010-2017 100
5.2.7 Hematology Analyzers Market, China, Revenue ($m), by Segment, 2017-2024 102
5.2.8 Hematology Cell Counters Market, China, Revenue ($m), by Segment, 2017-2024 104
5.2.9 Hematology Rapid Tests & POC Market, China, Revenue ($m), by Segment, 2017-2024 106
5.2.10 Hematology Reagents Market, China, Revenue ($m), by Segment, 2017-2024 108
5.2.11 Hemostasis Market, China, Revenue ($m), by Segment, 2017-2024 110
5.2.12 Immunohematology Market, China, Revenue ($m), by Segment, 2017-2024 112
5.3 Hematology Market, China, Volume (Units), 2010-2017 114
5.4 Hematology Market, China, Volume (Units), 2017-2024 116
5.4.1 Hematology Analyzers Market, China, Volume (Units), by Segment, 2010-2017 118
5.4.2 Hematology Rapid Tests & POC Market, China, Volume (Units), by Segment, 2010-2017 120
5.4.3 Hematology Reagents Market, China, Volume (Units), by Segment, 2010-2017 122
5.4.4 Hemostasis Market, China, Volume (Units), by Segment, 2010-2017 124
5.4.5 Hematology Analyzers Market, China, Volume (Units), by Segment, 2017-2024 126
5.4.6 Hematology Rapid Tests & POC Market, China, Volume (Units), by Segment, 2017-2024 128
5.4.7 Hematology Reagents Market, China, Volume (Units), by Segment, 2017-2024 130
5.4.8 Hemostasis Market, China, Volume (Units), by Segment, 2017-2024 132
5.5 Hematology Market, China, Average Price ($), 2010-2024 134
5.6 Hematology Market, China, Distribution Share by Revenue ($m), 2017 138
5.7 Hematology Market, China, Company Share by Revenue ($m), 2017 139
6 Hematology Market, India 141
6.1 Hematology Market, India, Revenue ($m), 2010-2017 141
6.2 Hematology Market, India, Revenue ($m), 2017-2024 143
6.2.1 Hematology Analyzers Market, India, Revenue ($m), by Segment, 2010-2017 145
6.2.2 Hematology Cell Counters Market, India, Revenue ($m), by Segment, 2010-2017 147
6.2.3 Hematology Rapid Tests & POC Market, India, Revenue ($m), by Segment, 2010-2017 149
6.2.4 Hematology Reagents Market, India, Revenue ($m), by Segment, 2010-2017 151
6.2.5 Hemostasis Market, India, Revenue ($m), by Segment, 2010-2017 153
6.2.6 Immunohematology Market, India, Revenue ($m), by Segment, 2010-2017 155
6.2.7 Hematology Analyzers Market, India, Revenue ($m), by Segment, 2017-2024 157
6.2.8 Hematology Cell Counters Market, India, Revenue ($m), by Segment, 2017-2024 159
6.2.9 Hematology Rapid Tests & POC Market, India, Revenue ($m), by Segment, 2017-2024 161
6.2.10 Hematology Reagents Market, India, Revenue ($m), by Segment, 2017-2024 163
6.2.11 Hemostasis Market, India, Revenue ($m), by Segment, 2017-2024 165
6.2.12 Immunohematology Market, India, Revenue ($m), by Segment, 2017-2024 167
6.3 Hematology Market, India, Volume (Units), 2010-2017 169
6.4 Hematology Market, India, Volume (Units), 2017-2024 171
6.4.1 Hematology Analyzers Market, India, Volume (Units), by Segment, 2010-2017 173
6.4.2 Hematology Rapid Tests & POC Market, India, Volume (Units), by Segment, 2010-2017 175
6.4.3 Hematology Reagents Market, India, Volume (Units), by Segment, 2010-2017 177
6.4.4 Hemostasis Market, India, Volume (Units), by Segment, 2010-2017 179
6.4.5 Hematology Analyzers Market, India, Volume (Units), by Segment, 2017-2024 181
6.4.6 Hematology Rapid Tests & POC Market, India, Volume (Units), by Segment, 2017-2024 183
6.4.7 Hematology Reagents Market, India, Volume (Units), by Segment, 2017-2024 185
6.4.8 Hemostasis Market, India, Volume (Units), by Segment, 2017-2024 187
6.5 Hematology Market, India, Average Price ($), 2010-2024 189
6.6 Hematology Market, India, Distribution Share by Revenue ($m), 2017 193
6.7 Hematology Market, India, Company Share by Revenue ($m), 2017 194
7 Hematology Market, Russia 196
7.1 Hematology Market, Russia, Revenue ($m), 2010-2017 196
7.2 Hematology Market, Russia, Revenue ($m), 2017-2024 198
7.2.1 Hematology Analyzers Market, Russia, Revenue ($m), by Segment, 2010-2017 200
7.2.2 Hematology Cell Counters Market, Russia, Revenue ($m), by Segment, 2010-2017 202
7.2.3 Hematology Rapid Tests & POC Market, Russia, Revenue ($m), by Segment, 2010-2017 204
7.2.4 Hematology Reagents Market, Russia, Revenue ($m), by Segment, 2010-2017 206
7.2.5 Hemostasis Market, Russia, Revenue ($m), by Segment, 2010-2017 208
7.2.6 Immunohematology Market, Russia, Revenue ($m), by Segment, 2010-2017 210
7.2.7 Hematology Analyzers Market, Russia, Revenue ($m), by Segment, 2017-2024 212
7.2.8 Hematology Cell Counters Market, Russia, Revenue ($m), by Segment, 2017-2024 214
7.2.9 Hematology Rapid Tests & POC Market, Russia, Revenue ($m), by Segment, 2017-2024 216
7.2.10 Hematology Reagents Market, Russia, Revenue ($m), by Segment, 2017-2024 218
7.2.11 Hemostasis Market, Russia, Revenue ($m), by Segment, 2017-2024 220
7.2.12 Immunohematology Market, Russia, Revenue ($m), by Segment, 2017-2024 222
7.3 Hematology Market, Russia, Volume (Units), 2010-2017 224
7.4 Hematology Market, Russia, Volume (Units), 2017-2024 226
7.4.1 Hematology Analyzers Market, Russia, Volume (Units), by Segment, 2010-2017 228
7.4.2 Hematology Rapid Tests & POC Market, Russia, Volume (Units), by Segment, 2010-2017 230
7.4.3 Hematology Reagents Market, Russia, Volume (Units), by Segment, 2010-2017 232
7.4.4 Hemostasis Market, Russia, Volume (Units), by Segment, 2010-2017 234
7.4.5 Hematology Analyzers Market, Russia, Volume (Units), by Segment, 2017-2024 236
7.4.6 Hematology Rapid Tests & POC Market, Russia, Volume (Units), by Segment, 2017-2024 238
7.4.7 Hematology Reagents Market, Russia, Volume (Units), by Segment, 2017-2024 240
7.4.8 Hemostasis Market, Russia, Volume (Units), by Segment, 2017-2024 242
7.5 Hematology Market, Russia, Average Price ($), 2010-2024 244
7.6 Hematology Market, Russia, Distribution Share by Revenue ($m), 2017 248
7.7 Hematology Market, Russia, Company Share by Revenue ($m), 2017 249
8 Overview of Key Companies in BRIC Hematology Market 251
8.1 Sysmex Corp 251
8.1.1 Company Overview 251
8.2 Siemens Healthcare GmbH 251
8.2.1 Company Overview 251
8.3 Beckman Coulter Inc 251
8.3.1 Company Overview 251
8.4 Mindray Medical International Ltd 251
8.4.1 Company Overview 251
8.5 F. Hoffmann-La Roche Ltd 252
8.5.1 Company Overview 252
8.6 Abbott Laboratories 252
8.6.1 Company Overview 252
8.7 Instrumentation Laboratory Company 252
8.7.1 Company Overview 252
8.8 Sigma-Aldrich Corp 252
8.8.1 Company Overview 252
8.9 bioMerieux SA 253
8.9.1 Company Overview 253
8.10 Thermo Fisher Scientific Inc 253
8.10.1 Company Overview 253
8.11 Horiba Ltd 253
8.11.1 Company Overview 253
8.12 Bio-Rad Laboratories Inc 253
8.12.1 Company Overview 253
8.13 Nihon Kohden Corp 254
8.13.1 Company Overview 254
8.14 Diagnostica Stago SAS 254
8.14.1 Company Overview 254
9 Hematology Market Pipeline Products 255
10 Appendix 256
10.1 Research Methodology 257
10.1.1 Coverage 257
10.1.2 Secondary Research 257
10.1.3 Primary Research 258
10.1.4 Market Modeling and Forecasting 259
10.1.5 Company Share Analysis 260
10.1.6 Distribution Share Analysis 261
10.1.7 Benchmarking 261
10.2 GlobalData Consulting 261
10.3 Contact Us 262
10.4 Disclaimer 262

1.1 List of Tables
Table 1: Hematology Market, Cross Country Comparison, BRIC, Revenue ($m), USD Constant, 2010-2024 16
Table 2: Hematology Market, BRIC, Category Comparison by Revenue ($m), USD Constant, 2010-2024 18
Table 3: Hematology Market, BRIC, Revenue ($m), Historic, USD Constant, 2010-2017 20
Table 4: Hematology Market, BRIC, Revenue ($m), Forecast, USD Constant, 2017-2024 22
Table 5: Hematology Market, BRIC, Volume (Units), 2010-2024 24
Table 6: Hematology Market, BRIC, Volume (Units), Historic, 2010-2017 26
Table 7: Hematology Market, BRIC, Volume (Units), Forecast, 2017-2024 28
Table 8: Hematology Market, BRIC, Company Share by Revenue ($m), USD Constant, 2017 30
Table 9: Hematology Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 32
Table 10: Hematology Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 34
Table 11: Hematology Analyzers Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 36
Table 12: Hematology Cell Counters Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 38
Table 13: Hematology Rapid Tests & POC Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 40
Table 14: Hematology Reagents Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 42
Table 15: Hemostasis Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 44
Table 16: Immunohematology Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 46
Table 17: Hematology Analyzers Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 48
Table 18: Hematology Cell Counters Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 50
Table 19: Hematology Rapid Tests & POC Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 52
Table 20: Hematology Reagents Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 54
Table 21: Hemostasis Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 56
Table 22: Immunohematology Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 58
Table 23: Hematology Market, Brazil, Volume (Units), Historic, 2010-2017 60
Table 24: Hematology Market, Brazil, Volume (Units), Forecast, 2017-2024 62
Table 25: Hematology Analyzers Market, Brazil, Volume (Units), Historic, 2010-2017 64
Table 26: Hematology Rapid Tests & POC Market, Brazil, Volume (Units), Historic, 2010-2017 66
Table 27: Hematology Reagents Market, Brazil, Volume (Units), Historic, 2010-2017 68
Table 28: Hemostasis Market, Brazil, Volume (Units), Historic, 2010-2017 70
Table 29: Hematology Analyzers Market, Brazil, Volume (Units), Forecast, 2017-2024 72
Table 30: Hematology Rapid Tests & POC Market, Brazil, Volume (Units), Forecast, 2017-2024 74
Table 31: Hematology Reagents Market, Brazil, Volume (Units), Forecast, 2017-2024 76
Table 32: Hemostasis Market, Brazil, Volume (Units), Forecast, 2017-2024 78
Table 33: Hematology Market, Brazil, Average Price ($) Historic, 2010-2017 79
Table 34: Hematology Market, Brazil, Average Price ($), Forecast, 2017-2024 81
Table 35: Hematology Market, Brazil, Distribution Share by Revenue ($m), USD Constant, 2017 83
Table 36: Hematology Market, Brazil, Company Share by Revenue ($m), USD Constant, 2017 85
Table 37: Hematology Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 87
Table 38: Hematology Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 89
Table 39: Hematology Analyzers Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 91
Table 40: Hematology Cell Counters Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 93
Table 41: Hematology Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 95
Table 42: Hematology Reagents Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 97
Table 43: Hemostasis Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 99
Table 44: Immunohematology Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 101
Table 45: Hematology Analyzers Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 103
Table 46: Hematology Cell Counters Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 105
Table 47: Hematology Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 107
Table 48: Hematology Reagents Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 109
Table 49: Hemostasis Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 111
Table 50: Immunohematology Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 113
Table 51: Hematology Market, China, Volume (Units), Historic, 2010-2017 115
Table 52: Hematology Market, China, Volume (Units), Forecast, 2017-2024 117
Table 53: Hematology Analyzers Market, China, Volume (Units), Historic, 2010-2017 119
Table 54: Hematology Rapid Tests & POC Market, China, Volume (Units), Historic, 2010-2017 121
Table 55: Hematology Reagents Market, China, Volume (Units), Historic, 2010-2017 123
Table 56: Hemostasis Market, China, Volume (Units), Historic, 2010-2017 125
Table 57: Hematology Analyzers Market, China, Volume (Units), Forecast, 2017-2024 127
Table 58: Hematology Rapid Tests & POC Market, China, Volume (Units), Forecast, 2017-2024 129
Table 59: Hematology Reagents Market, China, Volume (Units), Forecast, 2017-2024 131
Table 60: Hemostasis Market, China, Volume (Units), Forecast, 2017-2024 133
Table 61: Hematology Market, China, Average Price ($) Historic, 2010-2017 134
Table 62: Hematology Market, China, Average Price ($), Forecast, 2017-2024 136
Table 63: Hematology Market, China, Distribution Share by Revenue ($m), USD Constant, 2017 138
Table 64: Hematology Market, China, Company Share by Revenue ($m), USD Constant, 2017 140
Table 65: Hematology Market, India, Revenue ($m), USD Constant, Historic, 2010-2017 142
Table 66: Hematology Market, India, Revenue ($m), USD Constant, Forecast, 2017-2024 144
Table 67: Hematology Analyzers Market, India, Revenue ($m), USD Constant, Historic, 2010-2017 146
Table 68: Hematology Cell Counters Market, India, Revenue ($m), USD Constant, Historic, 2010-2017 148
Table 69: Hematology Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Historic, 2010-2017 150
Table 70: Hematology Reagents Market, India, Revenue ($m), USD Constant, Historic, 2010-2017 152
Table 71: Hemostasis Market, India, Revenue ($m), USD Constant, Historic, 2010-2017 154
Table 72: Immunohematology Market, India, Revenue ($m), USD Constant, Historic, 2010-2017 156
Table 73: Hematology Analyzers Market, India, Revenue ($m), USD Constant, Forecast, 2017-2024 158
Table 74: Hematology Cell Counters Market, India, Revenue ($m), USD Constant, Forecast, 2017-2024 160
Table 75: Hematology Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Forecast, 2017-2024 162
Table 76: Hematology Reagents Market, India, Revenue ($m), USD Constant, Forecast, 2017-2024 164
Table 77: Hemostasis Market, India, Revenue ($m), USD Constant, Forecast, 2017-2024 166
Table 78: Immunohematology Market, India, Revenue ($m), USD Constant, Forecast, 2017-2024 168
Table 79: Hematology Market, India, Volume (Units), Historic, 2010-2017 170
Table 80: Hematology Market, India, Volume (Units), Forecast, 2017-2024 172
Table 81: Hematology Analyzers Market, India, Volume (Units), Historic, 2010-2017 174
Table 82: Hematology Rapid Tests & POC Market, India, Volume (Units), Historic, 2010-2017 176
Table 83: Hematology Reagents Market, India, Volume (Units), Historic, 2010-2017 178
Table 84: Hemostasis Market, India, Volume (Units), Historic, 2010-2017 180
Table 85: Hematology Analyzers Market, India, Volume (Units), Forecast, 2017-2024 182
Table 86: Hematology Rapid Tests & POC Market, India, Volume (Units), Forecast, 2017-2024 184
Table 87: Hematology Reagents Market, India, Volume (Units), Forecast, 2017-2024 186
Table 88: Hemostasis Market, India, Volume (Units), Forecast, 2017-2024 188
Table 89: Hematology Market, India, Average Price ($) Historic, 2010-2017 189
Table 90: Hematology Market, India, Average Price ($), Forecast, 2017-2024 191
Table 91: Hematology Market, India, Distribution Share by Revenue ($m), USD Constant, 2017 193
Table 92: Hematology Market, India, Company Share by Revenue ($m), USD Constant, 2017 195
Table 93: Hematology Market, Russia, Revenue ($m), USD Constant, Historic, 2010-2017 197
Table 94: Hematology Market, Russia, Revenue ($m), USD Constant, Forecast, 2017-2024 199
Table 95: Hematology Analyzers Market, Russia, Revenue ($m), USD Constant, Historic, 2010-2017 201
Table 96: Hematology Cell Counters Market, Russia, Revenue ($m), USD Constant, Historic, 2010-2017 203
Table 97: Hematology Rapid Tests & POC Market, Russia, Revenue ($m), USD Constant, Historic, 2010-2017 205
Table 98: Hematology Reagents Market, Russia, Revenue ($m), USD Constant, Historic, 2010-2017 207
Table 99: Hemostasis Market, Russia, Revenue ($m), USD Constant, Historic, 2010-2017 209
Table 100: Immunohematology Market, Russia, Revenue ($m), USD Constant, Historic, 2010-2017 211
Table 101: Hematology Analyzers Market, Russia, Revenue ($m), USD Constant, Forecast, 2017-2024 213
Table 102: Hematology Cell Counters Market, Russia, Revenue ($m), USD Constant, Forecast, 2017-2024 215
Table 103: Hematology Rapid Tests & POC Market, Russia, Revenue ($m), USD Constant, Forecast, 2017-2024 217
Table 104: Hematology Reagents Market, Russia, Revenue ($m), USD Constant, Forecast, 2017-2024 219
Table 105: Hemostasis Market, Russia, Revenue ($m), USD Constant, Forecast, 2017-2024 221
Table 106: Immunohematology Market, Russia, Revenue ($m), USD Constant, Forecast, 2017-2024 223
Table 107: Hematology Market, Russia, Volume (Units), Historic, 2010-2017 225
Table 108: Hematology Market, Russia, Volume (Units), Forecast, 2017-2024 227
Table 109: Hematology Analyzers Market, Russia, Volume (Units), Historic, 2010-2017 229
Table 110: Hematology Rapid Tests & POC Market, Russia, Volume (Units), Historic, 2010-2017 231
Table 111: Hematology Reagents Market, Russia, Volume (Units), Historic, 2010-2017 233
Table 112: Hemostasis Market, Russia, Volume (Units), Historic, 2010-2017 235
Table 113: Hematology Analyzers Market, Russia, Volume (Units), Forecast, 2017-2024 237
Table 114: Hematology Rapid Tests & POC Market, Russia, Volume (Units), Forecast, 2017-2024 239
Table 115: Hematology Reagents Market, Russia, Volume (Units), Forecast, 2017-2024 241
Table 116: Hemostasis Market, Russia, Volume (Units), Forecast, 2017-2024 243
Table 117: Hematology Market, Russia, Average Price ($) Historic, 2010-2017 244
Table 118: Hematology Market, Russia, Average Price ($), Forecast, 2017-2024 246
Table 119: Hematology Market, Russia, Distribution Share by Revenue ($m), USD Constant, 2017 248
Table 120: Hematology Market, Russia, Company Share by Revenue ($m), USD Constant, 2017 250
Table 121: Hematology Market Pipeline Products 255
Table 122: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 259

1.2 List of Figures
Figure 1: Hematology Market, Cross Country Comparison, BRIC, Revenue ($m), USD Constant, 2010-2024 15
Figure 2: Hematology Market, BRIC, Category Comparison by Revenue ($m), USD Constant, 2010-2024 17
Figure 3: Hematology Market, BRIC, Revenue ($m), Historic, USD Constant, 2010-2017 19
Figure 4: Hematology Market, BRIC, Revenue ($m), Forecast, USD Constant, 2017-2024 21
Figure 5: Hematology Market, BRIC, Volume (Units), 2010-2024 23
Figure 6: Hematology Market, BRIC, Volume (Units), Historic, 2010-2017 25
Figure 7: Hematology Market, BRIC, Volume (Units), Forecast, 2017-2024 27
Figure 8: Hematology Market, BRIC, Company Share (%) 2017 29
Figure 9: Hematology Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 31
Figure 10: Hematology Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 33
Figure 11: Hematology Analyzers Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 35
Figure 12: Hematology Cell Counters Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 37
Figure 13: Hematology Rapid Tests & POC Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 39
Figure 14: Hematology Reagents Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 41
Figure 15: Hemostasis Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 43
Figure 16: Immunohematology Market, Brazil, Revenue ($m), USD Constant, Historic, 2010-2017 45
Figure 17: Hematology Analyzers Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 47
Figure 18: Hematology Cell Counters Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 49
Figure 19: Hematology Rapid Tests & POC Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 51
Figure 20: Hematology Reagents Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 53
Figure 21: Hemostasis Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 55
Figure 22: Immunohematology Market, Brazil, Revenue ($m), USD Constant, Forecast, 2017-2024 57
Figure 23: Hematology Market, Brazil, Volume (Units), Historic, 2010-2017 59
Figure 24: Hematology Market, Brazil, Volume (Units), Forecast, 2017-2024 61
Figure 25: Hematology Analyzers Market, Brazil, Volume (Units), Historic, 2010-2017 63
Figure 26: Hematology Rapid Tests & POC Market, Brazil, Volume (Units), Historic, 2010-2017 65
Figure 27: Hematology Reagents Market, Brazil, Volume (Units), Historic, 2010-2017 67
Figure 28: Hemostasis Market, Brazil, Volume (Units), Historic, 2010-2017 69
Figure 29: Hematology Analyzers Market, Brazil, Volume (Units), Forecast, 2017-2024 71
Figure 30: Hematology Rapid Tests & POC Market, Brazil, Volume (Units), Forecast, 2017-2024 73
Figure 31: Hematology Reagents Market, Brazil, Volume (Units), Forecast, 2017-2024 75
Figure 32: Hemostasis Market, Brazil, Volume (Units), Forecast, 2017-2024 77
Figure 33: Hematology Market, Brazil, Company Share (%) 2017 84
Figure 34: Hematology Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 86
Figure 35: Hematology Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 88
Figure 36: Hematology Analyzers Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 90
Figure 37: Hematology Cell Counters Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 92
Figure 38: Hematology Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 94
Figure 39: Hematology Reagents Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 96
Figure 40: Hemostasis Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 98
Figure 41: Immunohematology Market, China, Revenue ($m), USD Constant, Historic, 2010-2017 100
Figure 42: Hematology Analyzers Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 102
Figure 43: Hematology Cell Counters Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 104
Figure 44: Hematology Rapid Tests & POC Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 106
Figure 45: Hematology Reagents Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 108
Figure 46: Hemostasis Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 110
Figure 47: Immunohematology Market, China, Revenue ($m), USD Constant, Forecast, 2017-2024 112
Figure 48: Hematology Market, China, Volume (Units), Historic, 2010-2017 114
Figure 49: Hematology Market, China, Volume (Units), Forecast, 2017-2024 116
Figure 50: Hematology Analyzers Market, China, Volume (Units), Historic, 2010-2017 118
Figure 51: Hematology Rapid Tests & POC Market, China, Volume (Units), Historic, 2010-2017 120
Figure 52: Hematology Reagents Market, China, Volume (Units), Historic, 2010-2017 122
Figure 53: Hemostasis Market, China, Volume (Units), Historic, 2010-2017 124
Figure 54: Hematology Analyzers Market, China, Volume (Units), Forecast, 2017-2024 126
Figure 55: Hematology Rapid Tests & POC Market, China, Volume (Units), Forecast, 2017-2024 128
Figure 56: Hematology Reagents Market, China, Volume (Units), Forecast, 2017-2024 130
Figure 57: Hemostasis Market, China, Volume (Units), Forecast, 2017-2024 132
Figure 58: Hematology Market, China, Company Share (%) 2017 139
Figure 59: Hematology Market, India, Revenue ($m), USD Constant, Historic, 2010-2017 141
Figure 60: Hematology Market, India, Revenue ($m), USD Constant, Forecast, 2017-2024 143
Figure 61: Hematology Analyzers Market, India, Revenue ($m), USD Constant, Historic, 2010-2017 145
Figure 62: Hematology Cell Counters Market, India, Revenue ($m), USD Constant, Historic, 2010-2017 147
Figure 63: Hematology Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Historic, 2010-2017 149
Figure 64: Hematology Reagents Market, India, Revenue ($m), USD Constant, Historic, 2010-2017 151
Figure 65: Hemostasis Market, India, Revenue ($m), USD Constant, Historic, 2010-2017 153
Figure 66: Immunohematology Market, India, Revenue ($m), USD Constant, Historic, 2010-2017 155
Figure 67: Hematology Analyzers Market, India, Revenue ($m), USD Constant, Forecast, 2017-2024 157
Figure 68: Hematology Cell Counters Market, India, Revenue ($m), USD Constant, Forecast, 2017-2024 159
Figure 69: Hematology Rapid Tests & POC Market, India, Revenue ($m), USD Constant, Forecast, 2017-2024 161
Figure 70: Hematology Reagents Market, India, Revenue ($m), USD Constant, Forecast, 2017-2024 163
Figure 71: Hemostasis Market, India, Revenue ($m), USD Constant, Forecast, 2017-2024 165
Figure 72: Immunohematology Market, India, Revenue ($m), USD Constant, Forecast, 2017-2024 167
Figure 73: Hematology Market, India, Volume (Units), Historic, 2010-2017 169
Figure 74: Hematology Market, India, Volume (Units), Forecast, 2017-2024 171
Figure 75: Hematology Analyzers Market, India, Volume (Units), Historic, 2010-2017 173
Figure 76: Hematology Rapid Tests & POC Market, India, Volume (Units), Historic, 2010-2017 175
Figure 77: Hematology Reagents Market, India, Volume (Units), Historic, 2010-2017 177
Figure 78: Hemostasis Market, India, Volume (Units), Historic, 2010-2017 179
Figure 79: Hematology Analyzers Market, India, Volume (Units), Forecast, 2017-2024 181
Figure 80: Hematology Rapid Tests & POC Market, India, Volume (Units), Forecast, 2017-2024 183
Figure 81: Hematology Reagents Market, India, Volume (Units), Forecast, 2017-2024 185
Figure 82: Hemostasis Market, India, Volume (Units), Forecast, 2017-2024 187
Figure 83: Hematology Market, India, Company Share (%) 2017 194
Figure 84: Hematology Market, Russia, Revenue ($m), USD Constant, Historic, 2010-2017 196
Figure 85: Hematology Market, Russia, Revenue ($m), USD Constant, Forecast, 2017-2024 198
Figure 86: Hematology Analyzers Market, Russia, Revenue ($m), USD Constant, Historic, 2010-2017 200
Figure 87: Hematology Cell Counters Market, Russia, Revenue ($m), USD Constant, Historic, 2010-2017 202
Figure 88: Hematology Rapid Tests & POC Market, Russia, Revenue ($m), USD Constant, Historic, 2010-2017 204
Figure 89: Hematology Reagents Market, Russia, Revenue ($m), USD Constant, Historic, 2010-2017 206
Figure 90: Hemostasis Market, Russia, Revenue ($m), USD Constant, Historic, 2010-2017 208
Figure 91: Immunohematology Market, Russia, Revenue ($m), USD Constant, Historic, 2010-2017 210
Figure 92: Hematology Analyzers Market, Russia, Revenue ($m), USD Constant, Forecast, 2017-2024 212
Figure 93: Hematology Cell Counters Market, Russia, Revenue ($m), USD Constant, Forecast, 2017-2024 214
Figure 94: Hematology Rapid Tests & POC Market, Russia, Revenue ($m), USD Constant, Forecast, 2017-2024 216
Figure 95: Hematology Reagents Market, Russia, Revenue ($m), USD Constant, Forecast, 2017-2024 218
Figure 96: Hemostasis Market, Russia, Revenue ($m), USD Constant, Forecast, 2017-2024 220
Figure 97: Immunohematology Market, Russia, Revenue ($m), USD Constant, Forecast, 2017-2024 222
Figure 98: Hematology Market, Russia, Volume (Units), Historic, 2010-2017 224
Figure 99: Hematology Market, Russia, Volume (Units), Forecast, 2017-2024 226
Figure 100: Hematology Analyzers Market, Russia, Volume (Units), Historic, 2010-2017 228
Figure 101: Hematology Rapid Tests & POC Market, Russia, Volume (Units), Historic, 2010-2017 230
Figure 102: Hematology Reagents Market, Russia, Volume (Units), Historic, 2010-2017 232
Figure 103: Hemostasis Market, Russia, Volume (Units), Historic, 2010-2017 234
Figure 104: Hematology Analyzers Market, Russia, Volume (Units), Forecast, 2017-2024 236
Figure 105: Hematology Rapid Tests & POC Market, Russia, Volume (Units), Forecast, 2017-2024 238
Figure 106: Hematology Reagents Market, Russia, Volume (Units), Forecast, 2017-2024 240
Figure 107: Hemostasis Market, Russia, Volume (Units), Forecast, 2017-2024 242
Figure 108: Hematology Market, Russia, Company Share (%) 2017 249

Filed in: In Vitro Diagnostic, Medical Device

Publisher : GlobalData

Name:
Email:
Phone:
Subject:
Comments:

More Reports

Title	Price	Buy Now
In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026 “The global in vitro fertilization market size is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1 % during the forecast period” The global in vitro fertilization market is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1% from 2021 to 2026. The key factors fueling the growth of this market include an increase in the median age of first-time mothers, declining fertility rates, rising male infertility, rise in obesity rate and growing consumption of alcohol, and growing awareness about the availability of treatment options. However, the high cost and low success rate of IVF treatment and restrictive regulations and ethical concerns are expected to restrict the growth of the IVF market to a certain e......	$4950
Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact) Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) Summary Assisted Reproductive Technology Devices (General Surgery) - Global Market Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within General Surgery therapeutic area. The model discusses in detail the impact of COVID-19 on Assisted Reproductive Technology Devices market for the year 2020 and beyond. Assisted Reproductive Technology (ART) refers to reproductive health procedures that treat infertile women to achieve pregnancy. For decades now across much of the developed world, several techniques of ART have been in use with varying pregnancy success rates. These techniques primarily include, but are no......	$7500
Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact) Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model (COVID-19 Market Impact) Summary Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) - Global Analysis and Forecast Model (COVID-19 market impact) is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. The model discusses in detail the impact of COVID-19 on Multiparameter CT/NG NAAT Tests market for the year 2020 and beyond. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia Trachomatis. In women, Chlamydia Trachomatis infections are often asymptomatic, however, if left untreated they can cause pelvic inflammatory disease (PID), which in turn can lead to additional complications such as infertility, ectopic preg......	$7500
Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028 Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028 Summary Hemophilia A and B are rare, genetic, X-linked deficiencies in the blood clotting factors VIII (FVIII) and IX (FIX), respectively. Patients can be categorized as mild, moderate or severe depending on the percentage of circulating FVIII or FIX in their blood. Patients can be treated either on-demand or prophylactically using plasma-derived or recombinant replacement factors, the current standard of care. Although these therapies are effective, they are associated with a great treatment burden. There is a significant unmet need for new therapies that can reduce the great treatment burden associated with intravenous administration, the frequency of prophylactic infusions, and the risk of developing neutralizing a......	$10995
Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Human Immunodeficiency Virus (HIV) has become one of the world's most serious health issues affecting approximately 36.9 million people. The epidemiology of HIV infections varies from one geographical region to another. Sources indicate that in many countries, incidence rates for HIV have stabilized due to the campaigns that provide condoms, pre-exposure prophylaxis, sterile needles, syringes, antiretroviral therapy (ART), and prevention of mother-to-child transmission interv......	$7500
Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary Chlamydia Trachomatis Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia trachomatis. Patient access to Chlamydia screening, and thus the number of reported cases, varies substantially between countries. In some countries annual screening is recommended for specific patient groups deemed to be at higher risk of contracting the disease, such as sexually active females younger than 25 years. Additionally, screening of pregnant women for Chlamydia Trachomatis infections is currently recomme......	$7500
EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model Summary EGFR Tests (In Vitro Diagnostic) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Globally, lung cancer is the second most common cancer in men and the third most common cancer in women. There are two main types of lung cancer; small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC), with NSCLC accounting for approximately 80-90% of all lung cancer cases. The 5-year survival rate for patients with stage IV disease is less than 5% as majority of patients present with the advanced or metastatic disease at diagnosis. EGFR is a member of the receptor tyrosine kinase family and a major factor in regulating ......	$7500
Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cervical cancer screening has traditionally been based on cervical cytology. In recent years however, many countries have incorporated Human Papilloma Virus (HPV) tests into their cervical cancer and pre-cancer screening programs. Cytology based screening programs require a well-established healthcare infrastructure for processing and interpretation of samples. It is hoped that HPV screening methods may enable better prevention of these disease, these devices are also highly sensitive an......	$7500
Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model "Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Cytomegalovirus (CMV) represents the most common congenital, viral infection in the developed world and awareness of this disease is increasing. Few countries have official guidelines in place for CMV screening but in general testing tends to be performed for sperm donations, immunocompromised cases, and pregnant women. Diagnosis of CMV infections is complex as symptoms are often non-specific and mimic mononucleosis or the flu. Approximately 21-25% of primary CMV infections are symptomatic ......	$7500
Thyroid Function Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model Thyroid Function Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model Summary Thyroid Function Tests (In Vitro Diagnostics) - Global Market Analysis and Forecast Model is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area. Thyroid Disease is the second most common endocrine disease after diabetes. The term "Thyroid Disease" encapsulates a number of conditions, including hyperthyroidism and hypothyroidism. Due to the fact that clinical symptoms of thyroid disease can vary substantially between patients and are often not specific, these conditions tend to be diagnosed using biochemical assays. The number and types of thyroid function tests (TFTs) performed per case depends on various factors such as the level of thyroid hormones ......	$7500

BRIC Hematology Market Outlook to 2024

Benefits of Sandler Research

User License for Reports

Reach Us

Contact Us

Knowledge Store

Email Subscription

our Feed Reader

In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) – Global Forecast to 2026

Assisted Reproductive Technology Devices (General Surgery) – Global Market Analysis and Forecast Model (COVID-19 market impact)

Multiparameter CT/NG NAAT Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model (COVID-19 Market Impact)

Hemophilia A and B – Global Drug Forecast and Market Analysis to 2028

Human Immunodeficiency Virus (HIV) Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Chlamydia Trachomatis Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

EGFR Tests (In Vitro Diagnostic) – Global Market Analysis and Forecast Model

Human Papilloma Virus (HPV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Cytomegalovirus (CMV) Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model

Thyroid Function Tests (In Vitro Diagnostics) – Global Market Analysis and Forecast Model